Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-043832
Filing Date
2024-11-06
Accepted
2024-11-06 16:15:31
Documents
63
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1009211
2 ex31-1.htm EX-31.1 11024
3 ex31-2.htm EX-31.2 10945
4 ex32-1.htm EX-32.1 6935
5 ex32-2.htm EX-32.2 7409
  Complete submission text file 0001493152-24-043832.txt   4843599

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE aimd-20240930.xsd EX-101.SCH 36368
7 XBRL CALCULATION FILE aimd-20240930_cal.xml EX-101.CAL 48930
8 XBRL DEFINITION FILE aimd-20240930_def.xml EX-101.DEF 182444
9 XBRL LABEL FILE aimd-20240930_lab.xml EX-101.LAB 306604
10 XBRL PRESENTATION FILE aimd-20240930_pre.xml EX-101.PRE 249436
65 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 621717
Mailing Address AINOS, INC. 8880 RIO SAN DIEGO DRIVE SUITE 800 SAN DIEGO CA 92108
Business Address AINOS, INC. 8880 RIO SAN DIEGO DRIVE SUITE 800 SAN DIEGO CA 92108 858-869-2986
Ainos, Inc. (Filer) CIK: 0001014763 (see all company filings)

EIN.: 751974352 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41461 | Film No.: 241431162
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)